Entera Bio (ENTX) Enterprise Value Growth (1y) (2018 - 2026)
Entera Bio (ENTX) Enterprise Value Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Entera Bio | 186.78 Mn | 182.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 67.10% |
| Dec 31, 2025 | -71.86% |
| Sep 30, 2025 | -23.99% |
| Jun 30, 2025 | -19.90% |
| Mar 31, 2025 | -36.83% |
| Dec 31, 2024 | 21.41% |
| Sep 30, 2024 | 8.83% |
| Jun 30, 2024 | 0.86% |
| Mar 31, 2024 | 14.05% |
| Dec 31, 2023 | 10.48% |
| Sep 30, 2023 | 47.04% |
| Jun 30, 2023 | 47.13% |
| Mar 31, 2023 | 46.83% |
| Dec 31, 2022 | 50.55% |
| Sep 30, 2022 | 47.72% |
| Jun 30, 2022 | 37.82% |
| Mar 31, 2022 | -22.76% |
| Dec 31, 2021 | -181.14% |
| Jun 30, 2021 | -166.08% |
| Dec 31, 2020 | 42.35% |